Experts from India’s drug regulators recommended that the use of the Oxford-AstraZeneca and Bharat Biotech coronavirus vaccines be allowed in India, the government said on Saturday, paving the way for formal confirmation before which inoculations Massive events may begin in the second most populous country in the world. . The …
Read More »
The Government of India has granted approval in principle to two vaccines against Coronavirus, setting the stage for the deployment of the first phase of mass vaccination in the country. The Subject Matter Expert Committee (SEC) of the Central Organization for the Control of Medicines Standards recommended the granting of …
Read More »
NEW DELHI: An expert panel from India’s central drug authority on Saturday recommended granting permission for emergency use of the Covid-19 vaccine developed in the country Covaxin under certain conditions, a day after giving a similar address for the Oxford Covid-19 vaccine, the sources said. Covaxin has been developed indigenously …
Read More »
Aside from the Oxford / Astrazeneca vaccine, the other candidate vaccine that is set to gain restricted approval for emergency use in the coming days is Covaxin from Bharat Biotech. The Indian drug regulator’s panel of subject matter experts on Saturday recommended it for emergency use. While final nod goes …
Read More »
Bharat Biotech announced the successful recruitment of 23,000 volunteers and continued progress towards achieving the goal of 26,000 participants for the phase 3 clinical trial of its Covaxin coronavirus vaccine at multiple sites in India, the ANI news agency said citing the pharmaceutical firm on Saturday. The announcement came hours …
Read More »
India today carried out a nationwide Covid-19 vaccine trial as the country approaches to begin its massive rollout of Covid-19 vaccination to the general public. The vaccine testing exercise took place amid news from the government panel of experts recommending emergency approval restricted to two Covid-19 vaccines that are manufactured …
Read More »
Bharat Biotech vaccine candidate approved for use in clinical trial mode. The first COVID-19 vaccine developed in India, Covaxin, has been recommended for “restricted use in emergency situations, subject to multiple regulatory conditions” by the Subject Matter Expert Committee (SEC) of the Central Medicines Control Organization ( CDSCO), here on …
Read More »
An expert panel from India’s central drug authority on Saturday recommended granting permission for the restricted use of the indigenous COVID-19 vaccine developed by Bharat Biotech Covaxin in an emergency situation, especially in the context of infection by mutant strains, authorities said. The recommendation for the Bharat Biotech vaccine came …
Read More »
NEW DELHI: An expert panel from India’s drug authority recommended Saturday restricted emergency use of Bharat Biotechis Covaxin. The development comes one day after the recommended panel. emergency use authorization for the Serum Institute of India’s (SII) Covishield. The Central Medicines Control Organization (CDSCO) Subject Matter Expert Committee (SEC) on …
Read More »
Covaxin has been indigenously developed in collaboration with ICMR. An expert panel from India’s central drug authority recommended on January 2 to grant permission for the emergency restricted use of the locally developed COVID-19 vaccine Covaxin with certain conditions, a day after giving similar instructions for the COVID vaccine. -19 …
Read More »